Disrupting Japan

There are relatively few biotech startups in Japan. Few investors are willing to write the multi-million dollar checks and have the decades-long patience that is required to really succeed investing in this industry. But startups find a way, and an innovative biotech ecosystem has started to develop in Japan despite the lack of traditional funding. In fact, we might be seeing a new, uniquely Japanese, model of innovation that we'll call "the innovation supply chain". Today, we get a first-hand look at how this innovation supply chain functions, as we sit down with Yuki Shimahara the CEO and founder of LPixel.  LPixel uses AI image analysis to detect potential problems in patients MRI and CT scans. The technology itself is fascinating, but Yuki and I also talk about how medical research and medical innovation might be taking a very different path in Japan than it is in the West. It's a great conversation, and I think you'll really enjoy it. Show Notes The real problem with using AI for medical diagno